Recalls from Rising Pharma Holding, Inc.

• Rising Cyproheptadine Hydrochloride Syrup (opens in a new tab)
  Moderate risk, FDA, Jul 17, 2026, Foreign object
• Rising Pharmaceuticals Temozolomide Capsules, 5mg (opens in a new tab)
  Moderate risk, FDA, Mar 4, 2026, Drug impurity

Data: Recall Canary (opens in a new tab)